Status:
COMPLETED
Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.
Lead Sponsor:
University of Liege
Conditions:
Revision of Total Hip Arthroplasty
Eligibility:
All Genders
Brief Summary
Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we h...
Eligibility Criteria
Inclusion
- Eligible patients were adults undergoing elective aseptic revision of hip arthroplasty at the department of orthopedic surgery of the University Hospital of Liege between 01 January 2011 and 31 December 2020.
Exclusion
- Patients undergoing revision for infection or with local malignancies were excluded from this study.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05237830
Start Date
January 1 2011
End Date
January 31 2022
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Liège
Liège, Belgium, 4000